Non-Current Assets

Equity Securities (Non-Current)

Pfizer Equity Securities (Non-Current) increased by 1.7% to $653.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: equity_securities_noncurrent

Historical Data

2 periods
 Q4 '25Q1 '26
Value$642.00M$653.00M
QoQ Change—+1.7%
Range$642.00M – $653.00M

Equity Securities (Non-Current) at Other Companies

Amgen logo
AmgenAMGNView metric
Royalty Pharma logo
Royalty PharmaRPRXView metric

Frequently Asked Questions

What is Pfizer's equity securities (non-current)?
Pfizer (PFE) reported equity securities (non-current) of $653.00M in Q1 2026.